As previously reported, JAK2, as a key modulator of the immune response, is involved in the occurrence of graft-versus-host disease, a contributor to transplant-related mortality following allogeneic hematopoietic cell transplantation [8]. This evidence concerns the gene JAK2 and graft versus host disease.